Facile Synthesis of Chitosan Capped Mesoporous Silica Nanoparticles: A pH Responsive Smart Delivery Platform for Raloxifene Hydrochloride
- PMID: 29340980
- DOI: 10.1208/s12249-017-0949-0
Facile Synthesis of Chitosan Capped Mesoporous Silica Nanoparticles: A pH Responsive Smart Delivery Platform for Raloxifene Hydrochloride
Abstract
An encapsulation of model drug raloxifene hydrochloride (RAL) inside the chitosan decorated pH responsive mesoporous system has a greater potential for accumulating in the tumor cells. The present study involves synthesis of surface modified mesoporous silica nanoparticles (MSN) with the aim of achieving pH sensitive drug delivery system. A silanol skeleton of MSN has been productively modified to amine intermediate which served as a firm platform to adapt chitosan grafted assembly and systematically evaluated. RAL incorporation inside the featured mesopores was performed employing novel immersion solvent evaporation methodology and evaluated further. The pH responsive behavior of formulated nano framework was studied at three different pH of a phosphate buffer saline individually. The in vitro cell viability assay on MCF-7 breast carcinoma cells was performed in time and concentration dependent manner. Finally, the hemolysis assay of designed nanoparticle was accomplished to envisage the hemocompatibility. The outcome of characterization details unveiled a perfect 2D hexagonal spherical structure gifted with higher surface area and optimum pore size for designed nanoparticles. The higher percentage grafting of amine and chitosan residue, i.e., 4.01 and 28.51% respectively along with 31.89 and 33.57% RAL loading efficiency made MSNs more attractive and applicable. Eventually, in vitro release study exhibited higher RAL release in acidic media for extended time periods confirming successful formation of pH responsive nanoparticle having controlled release property. Conclusively potential of designed nanosystem to serve efficient anti-cancer remedy was confirmed by superior behaviour of chitosan grafted MSN towards MCF-7 cells with supreme hemocompatibility.
Keywords: MCF-7; anomalous release; chitosan; hemolysis assay; raloxifene hydrochloride.
Similar articles
-
Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.Chem Asian J. 2014 Jan;9(1):319-27. doi: 10.1002/asia.201301105. Epub 2013 Oct 2. Chem Asian J. 2014. PMID: 24115568
-
Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.Langmuir. 2013 Oct 15;29(41):12804-10. doi: 10.1021/la4022646. Epub 2013 Oct 3. Langmuir. 2013. PMID: 24073830
-
In-situ forming chitosan implant-loaded with raloxifene hydrochloride and bioactive glass nanoparticles for treatment of bone injuries: Formulation and biological evaluation in animal model.Int J Pharm. 2020 Apr 30;580:119213. doi: 10.1016/j.ijpharm.2020.119213. Epub 2020 Mar 9. Int J Pharm. 2020. PMID: 32165229
-
Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.Mini Rev Med Chem. 2018;18(11):976-989. doi: 10.2174/1389557516666160505114814. Mini Rev Med Chem. 2018. PMID: 27145854 Review.
-
Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.Curr Pharm Des. 2017;23(23):3367-3382. doi: 10.2174/1381612822666161025153619. Curr Pharm Des. 2017. PMID: 27784244 Review.
Cited by
-
Stimuli-Responsive Drug Release from Smart Polymers.J Funct Biomater. 2019 Jul 31;10(3):34. doi: 10.3390/jfb10030034. J Funct Biomater. 2019. PMID: 31370252 Free PMC article. Review.
-
Hybrid Mesoporous Nanoparticles for pH-Actuated Controlled Release.Nanomaterials (Basel). 2019 Mar 26;9(3):483. doi: 10.3390/nano9030483. Nanomaterials (Basel). 2019. PMID: 30917559 Free PMC article.
-
siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells.Sci Rep. 2021 Oct 15;11(1):20531. doi: 10.1038/s41598-021-00085-0. Sci Rep. 2021. PMID: 34654836 Free PMC article.
-
The Opportunities and Challenges of Silica Nanomaterial for Atherosclerosis.Int J Nanomedicine. 2021 Jan 28;16:701-714. doi: 10.2147/IJN.S290537. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33536755 Free PMC article. Review.
-
pH-responsive silica nanocarriers of olaparib for augmenting anticancer activity: development, characterization, and in vitro cytotoxicity study against MCF-7 breast cancer cells.3 Biotech. 2025 Jun;15(6):190. doi: 10.1007/s13205-025-04364-9. Epub 2025 May 27. 3 Biotech. 2025. PMID: 40443547
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous